ID: ALA3276693

Max Phase: Preclinical

Molecular Formula: C16H27NO

Molecular Weight: 249.40

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCNC(=O)C12CCCC3CC(CCC31)C2

Standard InChI:  InChI=1S/C16H27NO/c1-2-3-9-17-15(18)16-8-4-5-13-10-12(11-16)6-7-14(13)16/h12-14H,2-11H2,1H3,(H,17,18)

Standard InChI Key:  PWXGWYKJKXVGSZ-UHFFFAOYSA-N

Associated Targets(non-human)

Newcastle disease virus (78 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 249.40Molecular Weight (Monoisotopic): 249.2093AlogP: 3.51#Rotatable Bonds: 4
Polar Surface Area: 29.10Molecular Species: NEUTRALHBA: 1HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 0.74CX LogP: 3.56CX LogD: 3.56
Aromatic Rings: 0Heavy Atoms: 18QED Weighted: 0.76Np Likeness Score: 0.73

References

1. Aigami K, Inamoto Y, Takaishi N, Fujikura Y..  (1976)  Biologically active polycycloalkanes. 2. Antiviral 4-homoisotwistane derivatives.,  19  (4): [PMID:1263206] [10.1021/jm00226a018]

Source